|
Discussion Questions:
1. Should the US introduce some form of price regulation for medicines? If so, how?
2. Intellectual property protections - mainly in the form of patents - are supposed to create incentives for innovation - including drug development. How well do you think this is working? Are there any possible alternatives to the current model?
Readings:
a. Scannell J. Four Reasons Drugs Are Expensive, Of Which Two Are False.
Forbes.com October 13, 2015.
https://www.forbes.com/sites/matthewherper/2015/10/13/four-reasons-drugs-are-expensive-of-which-two-are-false/#767128974c3b
b. Light D, Lexchin J. Foreign free riders and the high price of US medicines BMJ 2005:331:958-60.
http://www.bmj.com/content/331/7522/958.full.pdf
c. Schrag D. The Price Tag on Progress — Chemotherapy for Colorectal Cancer. N Engl J Med 2004;351(4):317-319.
http://www.nejm.org/doi/pdf/10.1056/NEJMp048143
d. Lakdawalla DN,Goldman DP,Michaud PC, Sood N. US Pharmaceutical Policy In A Global Marketplace. Health Affairs 2009;28(1):w138- w150.
http://content.healthaffairs.org/content/28/1/w138.long
Active participation is required. This event is strongly recommended for students in the current and upcoming application cycles. The forum will help to prepare you for interviews and the CARS section of the
MCAT.
|
